NCT06063720

Brief Summary

This study prospectively evaluated the role of EWT versus SWT on adenoma detection rate (ADR) and other key quality metrics. In this prospective single-center study, patients undergoing colonoscopy were enrolled. EWT was calculated in real-time using an AI system with endoscopists blinded to the results. We performed multivariable analyses to assess the association of EWT and SWT with binary (e.g., ADR) and count outcomes (e.g., adenoma per colonoscopy \[APC\]), after adjusting for patient and procedural characteristics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
193

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 2, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
Last Updated

September 10, 2025

Status Verified

September 1, 2025

Enrollment Period

11 months

First QC Date

September 20, 2023

Last Update Submit

September 3, 2025

Conditions

Keywords

Colonic PolypArtificial intelligenceWithdrawal time

Outcome Measures

Primary Outcomes (1)

  • Adenoma detection rates

    Adenoma detection rates

    During the colonoscopy

Secondary Outcomes (7)

  • Polyp detection rate

    During that colonoscopy

  • Serrated lesion detection rate

    During colonoscopy

  • Advanced adenoma detection rate

    During colonoscopy

  • Adenoma per colonoscopy

    During colonoscopy

  • Polyp per colonoscopy

    During colonoscopy

  • +2 more secondary outcomes

Study Arms (1)

AI group

AI monitoring of effective withdrawal time

Device: Endoscreen QC

Interventions

Artificial intelligence monitoring of effective withdrawal time

AI group

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patient will be recruited in Queen Mary Hospital, Hong Kong, China

You may not qualify if:

  • history of inflammatory bowel disease
  • history of colorectal cancer
  • previous bowel resection (apart from appendectomy)
  • Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes
  • bleeding tendency or severe comorbid illnesses for which polypectomy is considered unsafe.
  • Cecum could not be intubated for various reasons
  • Poor bowel preparation with Boston Bowel Preparation Scale (BBPS) \< 6

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Mary Hospital, the University of Hong Kong

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Colonic Polyps

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Ka Luen Thomas Lui

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

September 20, 2023

First Posted

October 2, 2023

Study Start

November 1, 2023

Primary Completion

September 30, 2024

Study Completion

January 31, 2025

Last Updated

September 10, 2025

Record last verified: 2025-09

Locations